We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05399329
Brief Title: Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

First Submitted : May 26, 2022
First Submitted that Met QC Criteria : May 26, 2022
First Posted : June 1, 2022

Last Update Submitted that Met QC Criteria : December 15, 2022
Last Update Posted : December 16, 2022